- Home
- INDP vs PPBT Comparison
INDP vs PPBT Comparison
Compare INDP & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- PPBT
- Stock Information
- Founded
- INDP 2000
- PPBT 2010
- Country
- INDP United States
- PPBT Israel
- Employees
- INDP N/A
- PPBT N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- INDP Health Care
- PPBT Health Care
- Exchange
- INDP Nasdaq
- PPBT Nasdaq
- Market Cap
- INDP 15.4M
- PPBT 9.2M
- IPO Year
- INDP N/A
- PPBT N/A
- Fundamental
- Price
- INDP $1.18
- PPBT $4.80
- Analyst Decision
- INDP Strong Buy
- PPBT Strong Buy
- Analyst Count
- INDP 1
- PPBT 2
- Target Price
- INDP $12.00
- PPBT $126.50
- AVG Volume (30 Days)
- INDP 20.3K
- PPBT 45.3K
- Earning Date
- INDP 11-04-2024
- PPBT 11-19-2024
- Dividend Yield
- INDP N/A
- PPBT N/A
- EPS Growth
- INDP N/A
- PPBT N/A
- EPS
- INDP N/A
- PPBT N/A
- Revenue
- INDP N/A
- PPBT N/A
- Revenue This Year
- INDP N/A
- PPBT N/A
- Revenue Next Year
- INDP N/A
- PPBT N/A
- P/E Ratio
- INDP N/A
- PPBT N/A
- Revenue Growth
- INDP N/A
- PPBT N/A
- 52 Week Low
- INDP $1.03
- PPBT $4.43
- 52 Week High
- INDP $3.25
- PPBT $36.00
- Technical
- Relative Strength Index (RSI)
- INDP 37.66
- PPBT 29.60
- Support Level
- INDP $1.11
- PPBT $4.73
- Resistance Level
- INDP $1.22
- PPBT $5.92
- Average True Range (ATR)
- INDP 0.13
- PPBT 0.60
- MACD
- INDP -0.00
- PPBT -0.13
- Stochastic Oscillator
- INDP 28.30
- PPBT 2.43
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.